Product image of Oxaliplatin Kabi (Oxaliplatin) supplied by GNH India

Oxaliplatin Kabi

Active Ingredient:
Oxaliplatin
Origin:
EU

Oxaliplatin Kabi (Oxaliplatin)

Oxaliplatin, the active ingredient in Oxaliplatin Kabi, is a chemotherapy agent presented as a sterile solution for intravenous use. It is employed in the treatment of colorectal cancer and other gastrointestinal malignancies in adult patients. GNH India supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH India supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Fresenius Kabi D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oxaliplatin Kabi is used in colorectal cancer treatment protocols and related gastrointestinal oncology pathways.

  • Colorectal cancer: enhances tumor response when combined with fluoropyrimidine‑based regimens.
  • Gastric cancer: contributes to disease control in combination chemotherapy.
  • Pancreatic cancer: used off‑label in some regimens to improve response rates.
  • Esophageal cancer: added to multi‑drug protocols for potential benefit.
  • Metastatic disease: part of combination therapy to manage spread of gastrointestinal tumors.
  • Adjuvant therapy: employed after surgical resection to reduce recurrence risk.

How It Works

  • Oxaliplatin is a platinum‑based compound that forms DNA cross‑links after entering cancer cells. These cross‑links inhibit DNA replication and transcription, triggering apoptosis in rapidly dividing tumor cells. The drug’s activity is independent of the cellular mechanisms that confer resistance to older platinum agents, providing a distinct cytotoxic profile within chemotherapy regimens.

Side Effects

Oxaliplatin may cause a range of adverse reactions, from mild to severe, that require monitoring during treatment.

Common Side Effects

  • Nausea and vomiting: frequent gastrointestinal upset.
  • Peripheral neuropathy: tingling or numbness, often dose‑related.
  • Diarrhea: loose stools that may require supportive care.
  • Fatigue: generalized tiredness during therapy.
  • Myelosuppression: reduced blood cell counts.
  • Electrolyte disturbances: changes in potassium or magnesium levels.

Serious or Rare Side Effects

  • Severe allergic reactions: anaphylaxis or infusion‑related hypersensitivity.
  • Acute neurotoxicity: sudden onset of muscle cramps or difficulty breathing.
  • Cardiac arrhythmias: irregular heart rhythms observed during infusion.
  • Renal impairment: decreased kidney function requiring dose adjustment.
  • Hemolytic anemia: destruction of red blood cells.
  • Thrombotic events: blood clot formation in veins or arteries.

Precautions & Warnings

When using Oxaliplatin Kabi, clinicians should observe several safety measures to minimize risks.

  • Renal function assessment: evaluate baseline creatinine and glomerular filtration rate.
  • Neuropathy monitoring: conduct regular neurological examinations.
  • Hematologic surveillance: perform frequent complete blood counts.
  • Electrolyte management: check and correct potassium and magnesium levels.
  • Infusion rate control: administer over the recommended time to reduce toxicity.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Oxaliplatin Kabi can interact with other medicines, influencing its safety and effectiveness.

Major Interactions (Avoid)

  • Nephrotoxic agents: concurrent use may worsen kidney injury.
  • Myelosuppressive drugs: combined effect can cause severe bone‑marrow suppression.
  • Antioxidants (high dose): may reduce platinum‑drug efficacy.

Moderate Interactions (Monitor Closely)

  • Anti‑emetics: may require dose adjustment for optimal control of nausea.
  • Calcium channel blockers: potential for altered drug clearance.
  • NSAIDs: increased risk of renal dysfunction when used together.

Frequently Asked Questions

Oxaliplatin Kabi is a platinum‑based chemotherapy medication used primarily in combination regimens for colorectal cancer and other gastrointestinal malignancies. It is administered as part of first‑line, adjuvant, or metastatic treatment protocols to improve tumor response and reduce disease recurrence.

Oxaliplatin exerts its anticancer effect by forming covalent cross‑links with DNA inside tumor cells. These cross‑links block DNA replication and transcription, leading to programmed cell death (apoptosis). Its mechanism differs from older platinum agents, offering activity against tumors that may be resistant to other drugs.

The specific dose of Oxaliplatin Kabi is determined by the prescribing oncologist based on the patient’s cancer type, stage, body surface area, and overall health. Dosing regimens are individualized and should follow established clinical guidelines and the product’s prescribing information.

Oxaliplatin is classified as contraindicated in pregnancy because it can cross the placenta and cause fetal harm. It is also not recommended while breastfeeding, as it may be excreted in milk and affect the infant. Women of child‑bearing potential should use effective contraception during treatment.

To order, submit an enquiry on the Oxaliplatin Kabi product page at gnhindia.com, providing the required quantity and your institutional credentials. GNH India works with hospitals, pharmacies and procurement teams worldwide, then replies with pricing, availability, shipping details and any necessary import documentation.

Oxaliplatin differs from cisplatin and carboplatin in its chemical structure, which results in a distinct toxicity profile and activity against certain colorectal cancers. It typically causes less nephrotoxicity and ototoxicity than cisplatin but has a higher incidence of peripheral neuropathy. Choice of agent depends on tumor type, patient factors and treatment goals.

Oxaliplatin Kabi should be stored at ambient temperature, protected from light, and kept in its original packaging to maintain stability. Do not freeze the product, and follow standard aseptic handling procedures when preparing the intravenous solution.

Oxaliplatin Kabi is given as an intravenous infusion, typically diluted in a compatible IV fluid and administered over a set period according to the prescribing protocol. Administration is performed by qualified healthcare professionals in a clinical setting.

Serious risks include severe peripheral neuropathy, acute hypersensitivity reactions, significant myelosuppression, and rare cases of cardiac arrhythmias. Patients should be monitored closely for these events, and treatment should be adjusted or discontinued if severe toxicity occurs.

Oxaliplatin Kabi is contraindicated in patients with known hypersensitivity to platinum compounds, severe pre‑existing neuropathy, or significant renal impairment. It should also be avoided in pregnant women and those who are breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Oxaliplatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT